Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$317K Buy
6,577
+235
+4% +$12K 0.02% 272
2026
Q2
$332K Buy
6,342
+254
+4% +$13.4K 0.03% 229
2026
Q1
$336K Buy
6,088
+48
+0.8% +$2.6K 0.03% 202
2025
Q4
$296K Sell
6,040
-17
-0.3% -$793 0.03% 228
2025
Q3
$261K Buy
+6,057
New +$237K 0.03% 252

Other funds holding GSK

SYM Financial Corp's GSK Position: Q3 2026 in Review

SYM Financial Corp increased its GSK (GSK) stake by 3.7% in Q3 2026, buying an estimated $12K and bringing the position to 6,577 shares worth $317K. The position accounts for 0.02% of the portfolio, ranked #272.

SYM Financial Corp first reported a position in GSK in Q3 2025 and has held it in 5 quarters since. The position peaked at $336K in Q1 2026. 654 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • SYM Financial Corp held 6,577 shares of GSK worth $317K as of Q3 2026.
  • SYM Financial Corp bought 235 GSK shares in Q3 2026, an estimated $12K.
  • GSK made up 0.02% of SYM Financial Corp's portfolio in Q3 2026, its #272 holding.
  • SYM Financial Corp first reported a position in GSK in Q3 2025 and has held it in 5 quarters since.
  • SYM Financial Corp's GSK position peaked at $336K in Q1 2026.
  • 654 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on SYM Financial Corp's 13F filing for Q3 2026, filed 26 Oct 2026.